Literature DB >> 19794956

Multiple myeloma manifesting as a fluctuating sixth nerve palsy.

Jung Hwa Na1, Shin Hae Park, Sun Young Shin.   

Abstract

We report a case of multiple myeloma that presented as a fluctuating sixth cranial nerve palsy in the absence of widespread signs of systemic disease. A 63-year-old woman presented with horizontal diplopia of two weeks duration that subjectively changed over time. Ocular examination showed a fluctuating sixth nerve palsy. A computed tomography (CT) scan of the brain showed multiple, enhancing, soft tissue, mass-like lesions involving the left cavernous sinus and the apex of both petrous bones. Based on bone marrow biopsy and hematologic findings, she was diagnosed with multiple myeloma. Multiple myeloma may be included in the differential diagnosis of a fluctuating sixth nerve palsy, and although ophthalmic signs are rare and generally occur late in the course of multiple myeloma, they can still be its first signs.

Entities:  

Keywords:  Fluctuating; Multiple myeloma; Sixth cranial nerve palsy

Mesh:

Year:  2009        PMID: 19794956      PMCID: PMC2739975          DOI: 10.3341/kjo.2009.23.3.232

Source DB:  PubMed          Journal:  Korean J Ophthalmol        ISSN: 1011-8942


Ophthalmic manifestations of multiple myeloma are rare.1 Among these, neuro-ophthalmic manifestations are the commonest form of ophthalmic presentation, most frequently appearing as dysfunction of cranial nerves 2, 3 or 6. Sixth cranial nerve palsy is the most common cranial of these; however, it has rarely been described as the initial presenting feature of multiple myeloma.2,3 Herein, we report a case of fluctuating sixth nerve palsy as the first manifestation of multiple myeloma.

Case Report

A 63-year-old woman complained of horizontal diplopia of two weeks duration. She reported that the diplopia did not have a fixed pattern and was not aggravated by fatigue. There was no past ophthalmic or medical history of note. Upon first examination, her corrected visual acuity was 20/20 in both eyes. Her external ocular examination, intraocular pressures, and pupillary light reactions were all normal. The extraocular motility examination revealed abnormal abduction of the left eye, which never reached beyond the midline of the orbit. She had a left esotropia of 50-prism diopters (PD) at nearin primary position, 80PD in the left gaze, and 30PD in the right gaze (Fig. 1). The right ocular movement was not disturbed in any direction. One day later, she could abduct the left eye beyond the midline and had a left esotropia of 35PD at near in primary position, 50PD in the left gaze, and 14PD in the right gaze (Fig. 2), which showed improved abduction of the left eye (Fig. 2).
Fig. 1

Photograph of the patient upon first examination showing her inability to abduct the left eye beyond the midline.

Fig. 2

Photograph of the patient one day later showing only a moderate left abduction deficit.

Two weeks later, the motility examination again revealed a complete inability to abduct the left eye beyond the midline. Systemic examination was unremarkable. Serum acetylcholine receptor binding antibody and Tensilon test were negative. A computed tomography (CT) scan of the brain revealed multiple, enhancing, soft tissue, mass-like lesions involving the left cavernous sinus and the apex of both petrous bones (Fig. 3).
Fig. 3

Axial contrast-enhanced CT scan shows posterior bulging of the cavernous sinus with slight enhancement (arrow), suggesting a soft tissue mass within the cavernous sinus with mass effect.

Serum protein electrophoresis revealed two monoclonal components; IgAκ and free κ light chains. Bence-Jones protein was detected in urinary protein electrophoresis (1.4 g/l, with 83% of free κ light chains). Bone marrow biopsy revealed a hypercellular marrow with diffuse infiltration of atypical plasma cells, which accounted for about 60% of the total marrow cellularity. On the basis of these findings, a diagnosis of IgAκ-type multiple myeloma was made. Because of financial concerns, the patient refused treatment.

Discussion

Fluctuating weakness of extraocular muscles is known to be associated with myasthenia gravis. Previous reports have also documented fluctuating cranial nerve palsy due to an expanding basilar artery aneurysm,4 cerebellar astrocytoma,5 and cavernous sinus meningioma.6 However, we are not aware of any previous English-language reports of a case of fluctuating sixth nerve palsy associated with multiple myeloma, nor could we find any such references in a computerized search utilizing MEDLINE. The mechanism of sixth cranial nerve palsy in multiple myeloma may include the following: hematologic effect, compression, meningeal metastasis, or direct infiltration of the nerve itself.1 One possible explanation is that the mobility of this nerve within the cavernous sinus probably allowed for the fluctuation of symptoms in this patient. According to the movement of the sixth cranial nerve, the degree of compression might vary. Alternatively, it is assumed that the cystic lesion would present in the neighborhood of sixth cranial nerve. A fluctuating sign may be attributed to the varying pressure inside cystic lesion. The best assessment of the cavernous region is achieved by magnetic resonance imaging (MRI).7 Unfortunately, MRI of brain was not performed in this case because of financial concerns. Generally, the prognosis of multiple myeloma associated with intracranial lesions is poor. Various treatments have been tried, including intravenous or intrathecal chemotherapy and cranial irradiation. However, responses are usually partial and short-lived, with results achieved only after irradiation.7 In summary, this fluctuating sixth cranial nerve palsy is a first manifestation of multiple myeloma. We suggest that multiple myeloma should be included in the differential diagnosis of any fluctuating sixth cranial nerve palsy. Although ophthalmic signs are rare and generally occur late in the course of multiple myeloma, they can still be its first signs.
  7 in total

1.  Ophthalmic manifestations of multiple myeloma.

Authors:  Shirley Fung; Dinesh Selva; Igal Leibovitch; James Hsuan; John Crompton
Journal:  Ophthalmologica       Date:  2005 Jan-Feb       Impact factor: 3.250

2.  Bilateral fluctuating trochlear nerve palsy secondary to cerebellar astrocytoma.

Authors:  W F Astle; S J Miller
Journal:  Can J Ophthalmol       Date:  1994-02       Impact factor: 1.882

3.  Sixth nerve palsy as a presenting sign of intracranial plasmacytoma and multiple myeloma.

Authors:  T Z Movsas; L J Balcer; E R Eggenberger; J L Hess; S L Galetta
Journal:  J Neuroophthalmol       Date:  2000-12       Impact factor: 3.042

4.  Uncovering ocular pseudomyasthenia.

Authors:  J P Glass; J Halpern; R G Grossman
Journal:  Ann Ophthalmol       Date:  1993-11

5.  Multiple myeloma involving the cavernous sinus: a report of 3 cases and response to bortezomib.

Authors:  Alessandro Gozzetti; Alfonso Cerase; Annachiara Tarantino; Alberto Fabbri; Monica Bocchia; Maria Teresa Pirrotta; Francesco Lauria
Journal:  Clin Lymphoma Myeloma       Date:  2007-03

6.  Cavernous sinus syndrome as the initial manifestation of multiple myeloma.

Authors:  S Lam; C E Margo; R Beck; T J Pusateri; S Pascucci
Journal:  J Clin Neuroophthalmol       Date:  1987-09

7.  Pupil-sparing, painless compression of the oculomotor nerve by expanding basilar artery aneurysm: a case of ocular pseudomyasthenia.

Authors:  Bela Ajtai; Ed J Fine; Norah Lincoff
Journal:  Arch Neurol       Date:  2004-09
  7 in total
  4 in total

1.  Arachnoid cyst in the internal auditory canal causing fluctuating facial paresis in a child.

Authors:  Sumit Thakar; Sunil V Furtado; Alangar S Hegde
Journal:  Childs Nerv Syst       Date:  2011-04-19       Impact factor: 1.475

2.  Ophthalmic manifestations of atypical IgD multiple myeloma.

Authors:  Matthew R Edmunds; Peter Cikatricis; Subhanjan Mukherji; Jeremy D Bowyer
Journal:  BMJ Case Rep       Date:  2012-07-19

3.  A rare entity in multiple myeloma: six nerve paralysis.

Authors:  Guven Cetin; M Cem Ar; Abdullah Cerit; Kubra Gozubenli; Simge Erdem; Gulistan Halac
Journal:  Indian J Hematol Blood Transfus       Date:  2013-04-26       Impact factor: 0.900

4.  [Skull base metastases with cranial nerve deficits : Clinical profile of a severe disease].

Authors:  J Hoppe; T Kalckreuth; M Metelmann; J J Rumpf; S Klagges; S Dietzsch; C Scherlach; T Kuhnt; R D Kortmann; C Seidel
Journal:  Nervenarzt       Date:  2022-01-13       Impact factor: 1.297

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.